Publishing research using ab68193? Please let us know so that we can cite the reference in this datasheet.
ab68193 has been referenced in 5 publications.
Chen D et al.Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway.Cell Death Dis 9:123 (2018).
Qiao LN et al.Effect of electroacupuncture on thermal pain threshold and expression of calcitonin-gene related peptide, substance P and ?-aminobutyric acid in the cervical dorsal root ganglion of rats with incisional neck pain.Acupunct Med 35:276-283 (2017).
Lebok P et al.High levels of class III ß-tubulin expression are associated with aggressive tumor features in breast cancer.Oncol Lett 11:1987-1994 (2016).
Kanmert D et al.C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death.J Neurosci 35:10851-65 (2015).
Listwak SJ et al.Minimal NF-?B activity in neurons.Neuroscience 250:282-99 (2013).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up